Professor Walter Van Dyck contributes to business model for a European-wide health information ecosystem

Vlerick professor Walter Van Dyck has been appointed by the Innovative Medicines Initiative (IMI)  as a subject matter expert advising on the design and use of future health care business models enhancing biopharmaceutical R&D productivity and patient interaction in an era of personalised medicine.

The Innovative Medicines Initiative (IMI), a €2 billion euro budget joint undertaking between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA), is Europe's largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients.

Professor Walter Van Dyck is honoured by this appointment.On a personal level this is a recognition of my expertise in the field of healthcare business model design encompassing collaboration between life sciences companies, hospitals, and health management organisations. From a broader perspective on EU level this project is a key step in the transformation from classical to individualised medicine enabled by digitising humans.

Walter will function as the business modelling expert in a team of medical and biopharmaceutical researchers and health IT experts. “The goals is to design a business model for a European-wide health information ecosystem allowing researchers to link on an immense scale patient health records, genomic data, survey data, imaging and biosensor data, and social, environmental and economic data. This will speed up the development of complex individualised medicines and mobile health applications initially in the fields of obesity and Alzheimer’s disease.

Related news

  1. Taking a look at the neighbours: what Italy can teach Belgium about healthcare

    Date: 09/10/2014
    Category: Research News
    During each three-year term of office, MINOZ – the research centre for operational management in hospitals – organises a study trip for its members. In September, Professor Brecht Cardoen, Professor Paul Gemmel and researcher Rein Robberecht paid a visit to Milan, together with 30 participants from a total of 12 Belgian hospitals. Not only did they visit innovative hospitals, but the group also got to see how Italy tackles healthcare in general. What are the basic principles? How is it financed? Is it a competitive landscape? It turned out to be a very instructive trip.
  2. Launch of the Vlerick Healthcare Management Centre

    Date: 10/03/2014
    Category: Research News
    Healthcare is facing severe turmoil: patients are becoming more proactive in their treatment, while budgets are getting tighter. This is what prompted us to involve all the players within the healthcare system. The Vlerick Healthcare Management Centre is due to be launched later this year.
All articles